Collectively, studies suggest that three possible mechanisms are linked to the pathological role of CEBPB in LN: (1) CEBPB enhances NLRP3 inflammasome activation because the inhibition of CEBPB expression is associated with decreased NLRP3 levels [42]. Here, NLRP3 is linked to lobular neoplasia.